TWiV 908: COVID-19 clinical update #118 with Dr. Daniel Griffin

June 11, 2022

In COVID-19 clinical update #118, Dr. Griffin discusses management of hair loss after infection, FDA announcements on vaccine schedule and recommendations, Moderna announcement on bivalent booster candidate, association between vaccination and infection during pregnancy, population-level implications of Israel’s booster campaign, PAXLOVID outcomes during recent infection surge, efficacy and safety of Tixagevimab-cilgavimab, diagnostic accuracy of infection by canines, efficacy of colchicine in hospitalized patients, and factors associated with hospital readmission.  

Click arrow to play
Download TWiV 908 (29 MB .mp3, 48 min)
Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to

Leave a Reply

Your email address will not be published. Required fields are marked *

2 comments on “TWiV 908: COVID-19 clinical update #118 with Dr. Daniel Griffin

  1. Dave Christenson Jun 11, 2022

    Link to the “canine olfaction” paper, possibly add to show notes:

  2. Wow, joking about detection – in this case via dogs -, treatment methods – doctors who don’t know what they are talking about – and even laughing at possible fatalities due to withholding of certain medicamentation. Quite a way we have come in this pandamic. Have we become so rough during the two years that we can only cope with very dark humour? Or is it a banality at this point so we are allowed to make fun of it now? Makes you think…